Prairie Capital LP has recapitalized Family Allergy & Asthma, a group of board-certified allergists practicing at more than 20 locations throughout Kentucky and Indiana. No financial terms were disclosed. BB&T Capital Markets was the financial adviser to FA&A on the transaction.
On March 15, 2018, Family Allergy & Asthma (“FA&A” or the “Company”) was recapitalized by Prairie Capital L.P. (“Prairie”). BB&T Capital Markets served as the exclusive financial advisor to the Company and David Keys, head of Healthcare M&A, led the transaction.
BB&T Capital Markets’ M&A Advisory team provides process-oriented advisory expertise across multiple healthcare sectors. With nearly 15 years of M&A experience, the team has executed more than 35 transactions generating in excess of $3 billion of aggregate consideration for clients.